Neil F. Mcfarlane sold $225K of ZVRA stock

Neil F. Mcfarlane, President and CEO of Zevra Therapeutics, Inc. (ZVRA), sold 20,000 shares of ZVRA stock worth $225K, per an SEC Form 4 filed Oct 13, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade happened on Oct 10, 2026, 3 days before it was made public.

ZVRA has moved -2.0% since the trade date, from $11.39 to $11.16 (Nov 12, 2026 close).